CURE vs. INDL

Last updated Jun 13, 2026

CURE (Direxion Daily Healthcare Bull 3x Shares) and INDL (Direxion Daily India Bull 3x Shares) are both Leveraged Equities funds from Direxion - CURE tracks the Health Care Select Sector Index (300%) while INDL tracks the Indus India Index (300%). Both are passively managed. Over the past 10 years, CURE returned 13.49%/yr vs 0.22%/yr for INDL. At a 0.41 correlation, their price movements are largely independent. CURE charges 1.08%/yr vs 1.33%/yr for INDL.

Performance

CURE vs. INDL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily Healthcare Bull 3x Shares (CURE) and Direxion Daily India Bull 3x Shares (INDL). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CURE achieves a -7.96% return, which is significantly higher than INDL's -23.37% return. Over the past 10 years, CURE has outperformed INDL with an annualized return of 13.49%, while INDL has yielded a comparatively lower 0.22% annualized return.

CURE

• 1D: -0.55%
• 1M: 13.53%
• YTD: -7.96%
• 6M: -6.00%
• 1Y: 26.46%
• 3Y*: 3.05%
• 5Y*: 1.51%
• 10Y*: 13.49%

INDL

• 1D: 2.23%
• 1M: 0.60%
• YTD: -23.37%
• 6M: -20.84%
• 1Y: -28.42%
• 3Y*: -0.01%
• 5Y*: -2.48%
• 10Y*: 0.22%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CURE vs. INDL - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CURE Direxion Daily Healthcare Bull 3x Shares	-7.96%	22.55%	-8.47%	-9.40%	-20.51%	88.30%	5.02%	55.66%	2.82%	69.32%
INDL Direxion Daily India Bull 3x Shares	-23.37%	-3.21%	7.56%	26.06%	-22.88%	40.26%	-36.43%	3.15%	-34.29%	127.98%

Correlation

The correlation between CURE and INDL is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.26
Correlation (3Y) Calculated over the trailing 3-year period	0.28
Correlation (5Y) Calculated over the trailing 5-year period	0.36
Correlation (10Y) Calculated over the trailing 10-year period	0.38
Correlation (All Time) Calculated using the full available price history since Jun 15, 2011	0.41

The correlation between CURE and INDL shifts across timeframes, from 0.26 (1 year) to 0.41 (all time), reflecting how their relationship changes across market environments.

CURE vs. INDL - Sectors Allocation Comparison

Sectors	CURE	INDL
Healthcare	100.0%	6.1%
Basic Materials	-	8.6%
Communication Services	-	4.6%
Consumer Cyclical	-	12.4%
Consumer Defensive	-	6.3%
Energy	-	9.4%
Financial Services	-	28.3%
Industrials	-	10.3%
Real Estate	-	1.4%
Technology	-	8.2%
Utilities	-	4.5%

Return for Risk

CURE vs. INDL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CURE

CURE Risk / Return Rank: 21
CURE Sharpe Ratio Rank: 20
CURE Sortino Ratio Rank: 24
CURE Omega Ratio Rank: 22
CURE Calmar Ratio Rank: 22
CURE Martin Ratio Rank: 19

INDL

INDL Risk / Return Rank: 2
INDL Sharpe Ratio Rank: 2
INDL Sortino Ratio Rank: 2
INDL Omega Ratio Rank: 2
INDL Calmar Ratio Rank: 3
INDL Martin Ratio Rank: 1

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CURE vs. INDL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and Direxion Daily India Bull 3x Shares (INDL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CURE	INDL	Difference
Sharpe ratio: Return per unit of total volatility	0.60	-0.96	+1.56
Sortino ratio: Return per unit of downside risk	1.18	-1.37	+2.55
Omega ratio: Gain probability vs. loss probability	1.13	0.85	+0.28
Calmar ratio: Return relative to maximum drawdown	0.85	-0.75	+1.61
Martin ratio: Return relative to average drawdown	1.94	-1.55	+3.49

CURE vs. INDL - Sharpe Ratio Comparison

The current CURE Sharpe Ratio is 0.60, which is higher than the INDL Sharpe Ratio of -0.96. The chart below compares the historical Sharpe Ratios of CURE and INDL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

CURE vs. INDL - Drawdown Comparison

The maximum CURE drawdown since its inception was -69.19%, smaller than the maximum INDL drawdown of -95.67%. Use the drawdown chart below to compare losses from any high point for CURE and INDL.

Drawdown Indicators

	CURE	INDL	Difference
Max Drawdown Largest peak-to-trough decline	-69.19%	-95.67%	+26.48%
Max Drawdown (1Y) Largest decline over 1 year	-31.10%	-37.82%	+6.72%
Max Drawdown (3Y) Largest decline over 3 years	-51.93%	-47.64%	-4.29%
Max Drawdown (5Y) Largest decline over 5 years	-52.23%	-47.64%	-4.59%
Max Drawdown (10Y) Largest decline over 10 years	-69.19%	-91.96%	+22.77%
Current Drawdown Current decline from peak	-26.94%	-78.43%	+51.49%
Average Drawdown Average peak-to-trough decline	-18.16%	-66.36%	+48.20%
Ulcer Index Depth and duration of drawdowns from previous peaks	13.71%	18.35%	-4.64%

Volatility

CURE vs. INDL - Volatility Comparison

Direxion Daily Healthcare Bull 3x Shares (CURE) has a higher volatility of 14.30% compared to Direxion Daily India Bull 3x Shares (INDL) at 8.12%. This indicates that CURE's price experiences larger fluctuations and is considered to be riskier than INDL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CURE	INDL	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.30%	8.12%	+6.18%
Volatility (6M) Calculated over the trailing 6-month period	30.87%	25.59%	+5.28%
Volatility (1Y) Calculated over the trailing 1-year period	44.32%	29.71%	+14.61%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	43.84%	30.62%	+13.22%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	49.59%	52.69%	-3.10%

CURE vs. INDL - Expense Ratio Comparison

CURE has a 1.08% expense ratio, which is lower than INDL's 1.33% expense ratio.

Dividends

CURE vs. INDL - Dividend Comparison

CURE's dividend yield for the trailing twelve months is around 1.16%, less than INDL's 1.64% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
CURE Direxion Daily Healthcare Bull 3x Shares	1.16%	1.12%	1.17%	2.02%	0.38%	0.02%	0.17%	0.40%	0.70%	0.18%
INDL Direxion Daily India Bull 3x Shares	1.64%	1.42%	2.79%	1.65%	0.09%	2.35%	0.00%	0.68%	0.18%	0.31%

Frequently Asked Questions

Can I hold both CURE and INDL in my portfolio?

CURE and INDL have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CURE or INDL?

CURE has higher volatility (14.30%) compared to INDL (8.12%). In terms of maximum drawdown, CURE dropped -69.19% vs INDL's -95.67%.

Which ETF is better, CURE or INDL?

On 10-year performance, CURE leads with 13.49% vs 0.22% for INDL. On fees, CURE is cheaper at 1.08% per year. On volatility, INDL has been the lower-risk option at 8.12%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, CURE or INDL?

Over the 10-year period, CURE has performed better with a 13.49% return vs 0.22%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, CURE or INDL?

CURE is cheaper with a 1.08% expense ratio, compared with 1.33% for INDL.

Which ETF pays a higher dividend yield, CURE or INDL?

INDL has the higher dividend yield at 1.64%, compared with 1.16% for CURE.

What is the main difference between CURE and INDL?

CURE tracks Health Care Select Sector Index (300%), while INDL tracks Indus India Index (300%). Their fees differ too: 1.08% for CURE and 1.33% for INDL.

Which has better risk-adjusted returns?

CURE currently has the higher Sharpe Ratio (0.60 vs -0.96), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.